Aurora Cannabis: Underappreciated Turnaround

  • Aurora Cannabis remains a bullish opportunity due to its cheap valuation and an improving business model, despite recent stock weakness. International medical cannabis sales are growing, especially in Germany, but mixed global market dynamics and regulatory changes create volatility. Aurora's strong adjusted EBITDA, positive cash flow, and low debt position set the stage for potential upside if growth continues.